Friday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Questions on use of LDN in psoriasis, Lyme Disease, cancer, thyroid, diabetes, Crohn’s, MS, Lyme, vitiligo, other autoimmune diseases, administration route, dosing, nutrition, environmental toxins, LDN receptors, thymus proteins, peptides, stem cells, Vitamin D, insurance coverage for LDN, resources for testing and other treatments.

Saturday morning Q & A (2017 Conference) (LDN, low dose naltrexone)

Saturday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Dr Armin Schwarzbach - Lyme Disease (2014 Conference) (LDN, low dose naltrexone)

Stephen Dickson - The pharmacology of LDN (2014 Conference) (LDN, low dose naltrexone)

Pharmacist-Prescriber Michael McCaughley - LDN Specialist (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

The LDN Research Trust's 8th LDN Specialist

Pharmacist Masoud Rashidi, PharmD - LDN Specialist (LDN, low-dose Naltrexone) from LDN Research Trust on Vimeo.

Use of LDN for Chronic Pain - Sahar Swidan, PHARM.D., ABAAHP, FAARFM, FACA (2021 Conference) (LDN, low dose naltrexone)

This talk is on the use of LDN for chronic pain. She reviews LDN’s actions in the CNS and the PNS, the immunomodulating effect of LDN, and some clinical trials on the use of LDN.

The Use of LDN for Ophthalmic Conditions - Sebastian Denison, Pharm (2021 Conference) (LDN, low dose naltrexone)

This talk is about how they utilize LDN, their LDN protocol, and their outcomes and expectations. The information presented about humans can apply to animals as well.